Boston Scientific Corp - ESG Rating & Company Profile powered by AI
This Sustainability rating for Boston Scientific Corp represents its transparency towards the United Nations SDGs. The webpage includes a questions and answers table on Boston Scientific Corp. The Disclosure rating includes seventeen United Nations SDGs including: 'Affordable & Clean Energy', 'Climate Action' and 'Life below Water'.
Boston Scientific Corp in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Boston Scientific Corp | 8.0 | High |
1 | Calmark Sweden AB | 8.0 | High |
1 | CHC Healthcare Group | 8.0 | High |
... | ... | ... | |
260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
260 | Zynex Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Boston Scientific Corp have an accelerator or VC vehicle to help deliver innovation?
Does Boston Scientific Corp disclose current and historical energy intensity?
Does Boston Scientific Corp report the average age of the workforce?
Does Boston Scientific Corp reference operational or capital allocation in relation to climate change?
Does Boston Scientific Corp disclose its ethnicity pay gap?
Does Boston Scientific Corp disclose cybersecurity risks?
Does Boston Scientific Corp offer flexible work?
Does Boston Scientific Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Boston Scientific Corp disclose the number of employees in R&D functions?
Does Boston Scientific Corp conduct supply chain audits?
Does Boston Scientific Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Boston Scientific Corp conduct 360 degree staff reviews?
Does Boston Scientific Corp disclose the individual responsible for D&I?
Does Boston Scientific Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Boston Scientific Corp disclose current and / or historical scope 2 emissions?
Does Boston Scientific Corp disclose water use targets?
Does Boston Scientific Corp have careers partnerships with academic institutions?
Did Boston Scientific Corp have a product recall in the last two years?
Does Boston Scientific Corp disclose incidents of discrimination?
Does Boston Scientific Corp allow for Work Councils/Collective Agreements to be formed?
Has Boston Scientific Corp issued a profit warning in the past 24 months?
Does Boston Scientific Corp disclose parental leave metrics?
Does Boston Scientific Corp disclose climate scenario or pathway analysis?
Does Boston Scientific Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Boston Scientific Corp disclose the pay ratio of women to men?
Does Boston Scientific Corp support suppliers with sustainability related research and development?
Does Boston Scientific Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Boston Scientific Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Boston Scientific Corp involved in embryonic stem cell research?
Does Boston Scientific Corp disclose GHG and Air Emissions intensity?
Does Boston Scientific Corp disclose its waste policy?
Does Boston Scientific Corp report according to TCFD requirements?
Does Boston Scientific Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Boston Scientific Corp disclose energy use targets?
Does Boston Scientific Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Boston Scientific Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Boston Scientific Corp
These potential risks are based on the size, segment and geographies of the company.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.